Variant report
Variant | esv3404199 |
---|---|
Chromosome Location | chr13:39561402-39563800 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:39559201..39562021-chr13:39568354..39570299,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557493170 | chr13:39561412-39561413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138412618 | chr13:39561446-39561447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553520150 | chr13:39561466-39561467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537470295 | chr13:39561513-39561514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557412208 | chr13:39561515-39561516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113898074 | chr13:39561517-39561518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536753954 | chr13:39561528-39561529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542414811 | chr13:39561529-39561530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189902806 | chr13:39561567-39561568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564186880 | chr13:39561593-39561594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562206097 | chr13:39561596-39561597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575886443 | chr13:39561637-39561638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572246741 | chr13:39561654-39561655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144075117 | chr13:39561738-39561739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148244250 | chr13:39561760-39561761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577540399 | chr13:39561814-39561815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12857215 | chr13:39561853-39561854 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs12854781 | chr13:39561911-39561912 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs12857571 | chr13:39561917-39561918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111286683 | chr13:39561949-39561950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552093702 | chr13:39561968-39561969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562951719 | chr13:39561997-39561998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183190476 | chr13:39562025-39562026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548122132 | chr13:39562031-39562032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186499993 | chr13:39562063-39562064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556513488 | chr13:39562069-39562070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191707660 | chr13:39562101-39562102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183534931 | chr13:39562148-39562149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188884422 | chr13:39562164-39562165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192480926 | chr13:39562199-39562200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183552474 | chr13:39562226-39562227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186687605 | chr13:39562232-39562233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549106641 | chr13:39562234-39562235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191557334 | chr13:39562260-39562261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184737081 | chr13:39562271-39562272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189669061 | chr13:39562297-39562298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs193016441 | chr13:39562302-39562303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185210388 | chr13:39562353-39562354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs189097061 | chr13:39562373-39562374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368101314 | chr13:39562408-39562409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181868077 | chr13:39562423-39562424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186385388 | chr13:39562441-39562442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188099650 | chr13:39562443-39562444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs111216618 | chr13:39562462-39562463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559681345 | chr13:39562463-39562464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528717677 | chr13:39562466-39562467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs180941228 | chr13:39562471-39562472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368573839 | chr13:39562479-39562480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371983577 | chr13:39562499-39562500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186413619 | chr13:39562512-39562513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:39555600-39564600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr13:39555600-39564600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
3 | chr13:39561000-39561600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:39561000-39564600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr13:39561400-39564400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
6 | chr13:39561600-39564200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |